RE:RE:RE:RE:What kills credibility Biotech investments are risky business compared to other industries. Usually very small gains short term, but suddenly one day down to line the reward can be anywhere between 10 and 100 times the investment that balance the risk.
Anti-aging is the main compound here and the clinical results absolutely brilliant with room for improvement with another formulation. The risk has decreased significantly and now it's about spreading the word in the industry before the bidding process begin.
Seems like investors doesn't understand the magnitude here. Why people sell their shares for peanuts goes beyond my mind, probably the best investment opportunity in the industry now.
And no, the management will not give away this one for free. R+F was street cred and to some extent Abbvie as well. This is the real deal.